Alcoholism abolishes the gamma-aminobutyric acid (GABA)ergic control of GH secretion in humans

Alcohol

Volumn 16, Issue 4, 1998, Pages 325-328

  Vescovi, P P ^a   Volpi, R ^a   Coiro, V ^a  

^a Centro di Alcologia   (Italy)

Author keywords

GABA receptors; Gamma aminobutyric acid (GABA); Growth hormone secretion

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; BACLOFEN; GROWTH HORMONE; VALPROIC ACID;

ADULT; ALCOHOLISM; ARTICLE; DRUG RECEPTOR BINDING; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN;

ADULT; ALCOHOLISM; BACLOFEN; GABA AGENTS; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMAN GROWTH HORMONE; HUMANS; KINETICS; MALE; MIDDLE AGED; VALPROIC ACID;

EID: 0031756202     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(98)00023-8     Document Type: Article

References (28)

1. Berrettini W.H., Post R.M. GABA in affective illness. Post R.M., Ballenger J.C. Neurobiology of mood disorders. 1984;673-685 Williams & Wilkins, Baltimore.
2. Bowery N.G. Baclofen. 10 years on Trends Pharmacol. Sci. 3:1982;400-403.
3. Cicero T.J. Neuroendocrinological effects of alcohol. Annu. Rev. Med. 32:1981;123-142.
4. Coiro V., Vescovi P.P. Alcoholism abolishes the growth hormone response to sumatriptan administration in man. Metabolism. 44:1995;1577-1580.
5. Coiro V., Capretti L., Bianconi L., Castelli A., Cerri L., Roberti G., Marcato A., Volpi R., Chiodera P. Reduction of baclofen-, but not sodium valproate-induced growth hormone release in type I diabetic men. Horm. Metab. Res. 23:1991;600-604.
6. De Marinis L., Mancini A., Fiumara C. Growth hormone response to growth hormone-releasing hormone in early abstinent alcoholic patients. Psychoneuroendocrinology. 18:1993;475-483.
7. Dieguez C., Page M.D., Scanlon M.F. Growth hormone neuroregulation and its alterations in disease states. Clin. Endocrinol. 28:1988;109-143.
8. Enna S.J., Mohler H. Gamma-aminobutyric acid (GABA) receptors and their association with benzodiazepine recognition sites. Meltzer H.Y. Psychopharmacology. The third generation of progress:1991;265-272 Raven Press, New York.
9. Gamse R., Vaccaro D.E., Gamse G., Di Pace M., Fox T.O., Leeman S.E. Release of immunoreactive somatostatin from hypothalamic cells in culture. Inhibition by gamma-aminobutyric acid Proc. Natl. Acad. Sci. USA. 77:1980;552-5556.
10. Godin Y., Heiner L., Mark J., Mandel P. Effects of di-N-propylacetate, an anticonvulsant compound on GABA metabolism. J. Neurochem. 16:1969;869-873.
11. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56-62.
12. B receptors on GABAergic inhibitory neurons from embryonic rat hippocampus. Neurosci Lett. 85:1988;105-109.
13. Kelly P., Moore K. Dopamine concentrations in the rat brain following injections into substantia nigra of baclofen, gamma-amino-butyric acid, gamma-hydroxybutiric acid, apomorphine and amphetamine. Neuropharmacology. 17:1978;69-174.
14. Koulu M., Lammintausta R., Dahlstrom S. Effects of some gamma-aminobutyric acid (GABA)-ergic drugs on the dopaminergic control of human growth hormone secretion. J. Clin. Endocrinol. Metab. 51:1980;124-129.
15. Laakmann G., Treusch J., Eichmeier A., Schmauss M., Treusch U., Wahlster U. Inhibitory effect of phentolamine on diazepam-induced growth hormone secretion and lack of effect of diazepam on prolactin secretion in man. Psychoneuroendocrinology. 7:1982;135-139.
16. Marchesi C., Chiodera P., De Ferri A., De Risio C., Dassò L., Menozzi P., Volpi R., Coiro V. Reduction of GH response to the GAMMA-B agonist baclofen in patients with major depression. Psychoneuroendocrinology. 16:1991;475-479.
17. McCann S.M., Vijayane E., Nigro-Vilar A., Mizonuma H., Mangat H. Gamma aminobutyric acid (GABA), a modulator of anterior pituitary hormone secretion by hypothalamic and pituitary action. Psychoneuroendocrinology. 9:1984;97-106.
18. Mhatre M.C., Ticku M.K. Chronic ethanol administration alters gamma-aminobutyric acid A receptor gene expression. Mol. Pharmacol. 42:1992;415-419.
19. Morley J.E., Krahn D.D. Endocrinology for the psychiatrist. Nemeroff C., Loosen P.E. Clinical psychoneuroendocrinology. 1987;3-37 Guilford Press, New York.
20. Muller E.E. Neural control of somatotropic function. Physiol. Rev. 67:1987;962-1053.
21. Murakami Y., Kato Y., Kabayama Y., Tojo K., Inoue T., Imura H. Involvement of growth-releasing-factor in growth hormone secretion induced by gamma-aminobutyric acid in conscious rats. Endocrinology. 117:1985;787-789.
22. Naik S.R., Guidotti A., Costa E. Central GABA receptor agonists. A comparison of muscimol and baclofen Neuropharmacology. 15:1976;479-484.
23. Overstreet D.H., Rezvani A.H., Janowsky D.S. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol. Psychiatry. 31:1992;919-925.
24. Racagni G., Apud J.A., Cocchi D., Locatelli V., Muller E.E. GABAergic control of anterior pituitary hormone secretion. Life Sci. 31:1982;823-838.
25. + evoked release of methionine-enkephalin from rat striatal slices. Eur. J. Pharmacol. 70:1981;103-110.
26. Schalch D.S., Parker M.L. A sensitive double antibody immunoassay for human growth hormone in plasma. Nature. 203:1964;1141-1142.
27. Tappaz M.L. GABA and anterior pituitary function. anatomical data Psychoneuroendocrinology. 9:1984;85-95.
28. Tuomisto J., Mannisto P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacol. Rev. 37:1985;249-332.